Contact No: +91-8826373757 | +91-8826859373 | 011-25052216
Email: |

Article Access statistics

Viewed: 129

Emailed: 0

PDF Downloaded: 26

Current Opinion in Virus and Infectious Diseases - COVID

Status of hydroxychloroquine: COVID disease management protocol

Full Text PDF Share on Facebook Share on Twitter

Review Article

Author Details : S S Jha*

Volume : 1, Issue : 1, Year : 2020

Article Page : 6-10

Suggest article by email


Hydroxychloroquine, a safe derivative of chloroquine has been in practice since 1950. This drug has been used successfully as anti-viral agent previously. Its role in COVID-2 has been authenticated in the management protocol. The sudden death assigned to hydroxychloroquine is misplaced though it can be a very uncommon complication in cardiac patients with arrhythmia. Its prophylactic and therapeutic dose schedule needs to be streamlined at a lower dose schedule and is recommended to be used in early part of the disease and not during the stage of later complication.

Keywords: Hydroxychloroquine, Arrhythmia, Pathogen, Host target cell, ACE-2, Intracellular.

Doi : 10.18231/j.ijirm.2020.017

How to cite : Jha S S, Status of hydroxychloroquine: COVID disease management protocol. Covid-19 2020;1(1):6-10

Copyright © 2020 by author(s) and Covid-19. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (